Meeder Asset Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Meeder Asset Management’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-7,568	Closed	-$11K	–	2643
2019 Q4	$11K	Hold	7,568	–	–	﹤0.01%	1545
2019 Q3	$11K	Buy	7,568 +5,616	+288%	+$9.09K	﹤0.01%	1525
2019 Q2	$3K	Hold	1,952	–	–	﹤0.01%	1830
2019 Q1	$5K	Sell	1,952 -338	-15%	-$793	﹤0.01%	1417
2018 Q4	$4K	Sell	2,290 -2,932	-56%	-$8.23K	﹤0.01%	1490
2018 Q3	$23K	Buy	+5,222	New	+$29.6K	﹤0.01%	1004
2017 Q3	–	Sell	-98	Closed	-$1K	–	1817
2017 Q2	$1K	Sell	98 -278	-74%	-$2.1K	﹤0.01%	1585
2017 Q1	$3K	Sell	376 -2,724	-88%	-$16.9K	﹤0.01%	1305
2016 Q4	$18K	Buy	+3,100	New	+$21K	﹤0.01%	674

Other funds holding NEOS

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Meeder Asset Management's NEOS Position: Q1 2020 in Review

Meeder Asset Management sold out of Neos Therapeutics, Inc (NEOS) in Q1 2020, closing a stake of 7,568 shares — an estimated $11K sold.

Meeder Asset Management first reported a position in NEOS in Q4 2016 and held it in 9 quarters. The position peaked at $23K in Q3 2018. 49 funds tracked by Wall St. Rank hold NEOS as of Q1 2020.

Meeder Asset Management reported no remaining Neos Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Meeder Asset Management sold 7,568 Neos Therapeutics, Inc shares in Q1 2020, an estimated $11K.
Meeder Asset Management first reported a position in Neos Therapeutics, Inc in Q4 2016 and held it in 9 quarters.
Meeder Asset Management's Neos Therapeutics, Inc position peaked at $23K in Q3 2018.
49 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2020.

Based on Meeder Asset Management's 13F filing for Q1 2020, filed 15 May 2020.